Skip to main content
Log in

Medium-chain triglyceride loading test in carnitine–acylcarnitine translocase deficiency: Insights on treatment

  • Published:
Journal of Inherited Metabolic Disease

Abstract

The results of a medium-chain triglyceride loading test in a patient with severe carnitine–acylcarnitine translocase deficiency clearly demonstrated impaired in vivo utilization of medium-chain triglycerides. The loading test was performed at the ages of 7 and 36 months. The diet was adjusted accordingly. The clinical course has been favourable and the child is now in very good condition at age 4 years. We conclude that the utilization of medium-chain triglycerides is only partial in carnitine–acylcarnitine translocase deficiency and cannot reasonably be considered an optimal source of energy for these patients. Careful adjustment of dietetic treatment may help to improve prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bergman AJIW, Donckerwolcke AMG, Duran M, et al (1994) Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency. Pediatr Res 36: 582-588.

    Google Scholar 

  • Brivet M, Slama A, Ogier H, et al (1994) Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis. J Inher Metab Dis 17: 271-274.

    Google Scholar 

  • Brivet M, Slama A, Millington DS, et al (1996) Retrospective diagnosis of carnitine-acylcarnitine translocase deficiency by acylcarnitines analysis in the proband Guthrie card and enzymatic studies in the parents. J Inher Metab Dis 19: 181-184.

    Google Scholar 

  • Chalmers RA, Stanley CA, English N, Wigglesworth JS (1997) Mitochondrial carnitine-acylcarnitine translocase deÐciency presenting as sudden neonatal death. J Pediatr 131: 220-225.

    Google Scholar 

  • Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE (1989) Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83: 927-936.

    Google Scholar 

  • Di Donato S, Cornelio F, Storchi G, et al (1979) Hepatic ketogenesis and muscle carnitine deficiency. Neurology 29: 780-785.

    Google Scholar 

  • Dionisi Vici C, Garavaglia B, Bartuli A, et al (1995) Carnitine-acylcarnitine translocase deficiency: benign course without cardiac involvement. Pediatr Res 37: 147A.

    Google Scholar 

  • Garavaglia B, Uziel G, Dworzak F, et al (1991) Primary carnitine deficiency: heterozygote and intrafamilial phenotypic variation. Neurology 41: 1691-1693.

    Google Scholar 

  • Huizing M, Iacobazzi V, Ijlst L, et al (1997) Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am J Hum Genet 61: 1239-1245.

    Google Scholar 

  • Invernizzi F, Garavaglia B, Parini R, et al (1998) Molecular characterization of mitochondrial carnitine-acylcarnitine translocase deficiency. Am J Hum Genet 63: A268.

    Google Scholar 

  • McHowat J, Yamada KA, Saffitz JE, Corr PB (1993) Subcellular distribution of endogenous long chain acylcarnitines during hypoxia in adult canine myocytes. Cardiovasc Res 27: 1237-1243.

    Google Scholar 

  • Morris AA, Olpin SE, Brivet M, Turnbull DM, Jones RA, Leonard JV (1998) A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. J Pediatr 132: 514-516.

    Google Scholar 

  • Niezen-Koning J, Van Spronsen FJ, Ijlst, et al (1995) A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency. J Inher Metab Dis 18: 230-232.

    Google Scholar 

  • Olpin SE, Bonham JR, Downing M et al (1997) Carnitine-acylcarnitine translocase deficiency-a mild phenotype. J Inher Metab Dis 20: 714-715.

    Google Scholar 

  • Pande SV, Brivet M, Slama A, Demaugre F, Aufrant C, Saudubray JM (1993) Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculoventricular block. Translocase assay in permeabilized fibroblasts. J Clin Invest 91: 1247-1252.

    Google Scholar 

  • Parini R, Garavaglia B, Saudubray JM, et al (1991) Clinical diagnosis of long-chain acylcoenzyme A-dehydrogenase deficiency: use of stress and fat-loading tests. J Pediatr 119: 77-80.

    Google Scholar 

  • Parini R, Menni F, Garavaglia B, et al (1998) Acute, severe cardiomyopathy as main symptom of late-onset very-long-chain acyl-coenzyme A dehydrogenase deficiency. Eur J Pediatr 157: 992-995.

    Google Scholar 

  • Schaefer J, Jackson S, Taroni F, Swift P, Turnbull DM (1997) Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy. J Neurol Neurosurg Psychiatry 62: 169-176.

    Google Scholar 

  • Stanley CA (1995) Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, Van den Berghe G, eds. Inborn Metabolic Diseases. Berlin: Springer Verlag, 133-143.

    Google Scholar 

  • Stanley CA, Hale DE, Berry GT, Deleeuw S, Boxer J, Bonnefont JP (1992) Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N. Engl J Med 327: 19-22.

    Google Scholar 

  • Stanley CA, Berry GT, Bennett MJ, Willi SM, Treem WR, Hale DE (1993) Renal handling of carnitine in secondary carnitine deficiency disorders. Pediatr Res 34: 89-97.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parini, R., Invernizzi, F., Menni, F. et al. Medium-chain triglyceride loading test in carnitine–acylcarnitine translocase deficiency: Insights on treatment. J Inherit Metab Dis 22, 733–739 (1999). https://doi.org/10.1023/A:1005548201355

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005548201355

Keywords

Navigation